Novel treatments to tackle myelofibrosis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2018.1536538
Abstract: ABSTRACT Introduction: Despite the dramatic progress made in the treatment of patients with myelofibrosis since the introduction of the JAK1/2 inhibitor ruxolitinib, a therapeutic option that can modify the natural history of the disease and… read more here.
Keywords: medicine; treatments tackle; myelofibrosis; novel treatments ... See more keywords